Search Results - "Inclan Conde, M"

5PSQ-037 Importance and impact of pharmaceutical reconciliation at discharge in the elderly patient with polymedication by Vara Urruchua, M, Vila Gallego, C, Inclan Conde, M, Belio Aguera, B, Gomez Echevarria, N, Perez España, Z, Pardo Santos, NM, Aguirrezabala Arredondo, AV

“…Background and ImportanceMedication reconciliation is a key tool to increase patient safety and can be very useful in the polymedicated elderly.Aim and…”
Get full text

4CPS-050 Use of galcanezumab in patients with migraine in a tertiary hospital: health results by Revuelta Amallo, A, Vila Gallego, C, Vara Urruchua, M, Inclan Conde, M, Belio Aguera, B, Alvarez Lavin, M, Alonso Diez, M, Aguirrezabal Arredondo, A

“…Background and importanceGalcanezumab, a humanised monoclonal antibody that binds calcitonin gene-related peptide, has demonstrated a significant reduction in…”
Get full text

4CPS-242 Human immunodeficiency virus pre-exposure prophylaxis: analysis, follow-up and pandemic effect by Vila Gallego, C, Alvarez Lavin, MM, Alonso Diez, MM, Vara Urruchua, M, Revuelta Amallo, A, Inclan Conde, M, Pardo Santos, NM, Aguirrezabal Arredondo, AV, Muñoz Sanchez, J

“…Background and importanceIn 2019, the National Health System (NHS) approved funding for the indication of pre-exposure prophylaxis (PreP) as an strategy to…”
Get full text